Chinese English Japanese Korean

GL Biochem (Shanghai) Ltd

Firmenname:GL Biochem (Shanghai) Ltd
Telefon:21-61263452
E-Mail:ymbetter@glbiochem.com
Nationalität:China
URL: www.glschina.com/
Produkte insgesamt:9981
87 88 89 90 91 92 93 94 95 96 97 98 99 100

Produktkatalog

PKA Substrate, Catalytic Subunit;GRTGRRNSIC39H74N20O12
PKA, PKC, MAPKAP-K1 Substrate [RRRLSSLRA-NH2], 5-FAM labeled;5-FAM-RRRLSSLRA-NH2C66H98N22O17
PKA, PKC, MAPKAP-K1 Substrate [RRRLSSLRA-NH2], 5-TMR labeled;5-TMR-RRRLSSLRA-NH2C74H112ClN25O17
PKA, PKC, MAPKAP-K1 Substrate [RRRLSSLRA-NH2], Biotinylated;Biotin-RRRLSSLRA-NH2C55H102N24O13S
PKA, PKC, MAPKAP-K1 Substrate [RRRLSSLRA-NH2];RRRLSSLRA-NH2C45H88N22O11
PKC (19-31), myristoylated;Myristoyl-RFARKGALRQKNVC81H144N26O17
PKC Substrate [RRGR-pT-GRGRRGIFR], Phosphorylated;RRGR-pT-GRGRRGIFRC69H126N35O19P
PKC Substrate [RRGRTGRGRRGIFR], 5-FAM labeled;5-FAM-RRGRTGRGRRGIFRC90H135N35O22
PKC Substrate [RRGRTGRGRRGIFR], 5-TMR labeled;5-TMR-RRGRTGRGRRGIFRC98H149ClN38O22
PKC Substrate [RRGRTGRGRRGIFR], Biotinylated;Biotin-RRGRTGRGRRGIFRC79H139N37O18S
PKC Substrate [RRGRTGRGRRGIFR];RRGRTGRGRRGIFRC69H125N35O16
PKCe pseudosubstrate derived peptide, TAMRA-labeled??;5-TAMRA-ERMRPRKRQGSVRRV-NH2
PKCe pseudosubstrate derived peptide??;ERMRPRKRQGSVRRRV-NH2
PKCδ Substrate [RFAVRDMRQ-pT-VAVGVIKAVDKK], Phosphorylated;RFAVRDMRQ-pT-VAVGVIKAVDKKC109H192N35O32PS
PKCδ Substrate [RFAVRDMRQTVAVGVIKAVDKK], 5-FAM labeled;5-FAM-RFAVRDMRQTVAVGVIKAVDKKC130H201N35O35S
PKCδ Substrate [RFAVRDMRQTVAVGVIKAVDKK], 5-TMR labeled;5-TMR-RFAVRDMRQTVAVGVIKAVDKKC138H215ClN38O35S
PKCδ Substrate [RFAVRDMRQTVAVGVIKAVDKK], Biotinylated;Biotin-RFAVRDMRQTVAVGVIKAVDKKC119H205N37O31S2
PKCδ Substrate [RFAVRDMRQTVAVGVIKAVDKK];RFAVRDMRQTVAVGVIKAVDKKC109H191N35O29S
PKCμ Substrate [AALVRQM-pS-VAFFFK], Phosphorylated;AALVRQM-pS-VAFFFKC77H120N19O20PS
PKCμ Substrate [AALVRQMSVAFFFK], 5-FAM labeled;5-FAM-AALVRQMSVAFFFKC98H129N19O23S
PKCμ Substrate [AALVRQMSVAFFFK], 5-TMR labeled;5-TMR-AALVRQMSVAFFFKC106H143ClN22O23S
PKCμ Substrate [AALVRQMSVAFFFK], Biobinylated;Biotin-AALVRQMSVAFFFKC87H133N21O19S2
PKCμ Substrate [AALVRQMSVAFFFK];AALVRQMSVAFFFKC77H119N19O17S
PKG Substate [RKRSRAE], 5-FAM labeled;5-FAM-RKRSRAEC56H77N17O17
PKG Substate [RKRSRAE], 5-TMR labeled;5-TMR-RKRSRAEC64H91ClN20O17
PKG Substate [RKRSRAE], Biotinylated;Biotin-RKRSRAEC45H81N19O13S
PKG Substate [RKRSRAE], Phosphorylated;RKR-pS-RAEC35H68N17O14P
Platelet-Derived Growth Factor ?-Receptor (719-723);pY-VPMLC30H48N5O10PS
Platelet-Derived Growth Factor Receptor Substrate 1;N-pY-ISKGSTFLC52H81N12O19P
PLM derived peptide, TAMRA-labeled??;5-TAMRA-IRRLSTRRR-OH
pMOG (44-54)??;FSRVVHLYRNG
PRAME epitope (PRA300-309) Tumor-associated antigen;ALYVDSLFFLC60H86N10O15
Prepro-adrenomedullin (45-92), human;ELRMSSSYPTGLADVKAGPAQTLIRPQDMKGASRSPEDSSPDAARIRV
Propionyl-Beta-Amyloid (31-34), amide;Propionyl-IIGL-NH2256419-86-0C23H43N5O5
Prosaptide TX14(A);TaLIDNNATEEILYC69H110N16O26
Prosaptide, wild type;TKLIDNNKTEKEILC66H116N18O24
Prostate-Specific Antigen, PSA propeptide;APLILSRC35H64N10O9
Protein Kinase Cε Peptide Substrate [ERMRPRKRQG-pS-VRRRV], Phosphorylated;ERMRPRKRQG-pS-VRRRVC83H156N39O24PS
Protein Kinase Cε Peptide Substrate [ERMRPRKRQGSVRRRV], 5-FAM labeled;5-FAM-ERMRPRKRQGSVRRRVC104H165N39O27S
Protein Kinase Cε Peptide Substrate [ERMRPRKRQGSVRRRV], 5-TMR labeled;5-TMR-ERMRPRKRQGSVRRRVC112H179ClN42O27S
Protein Kinase Cε Peptide Substrate [ERMRPRKRQGSVRRRV], Biotinylated;Biotin-ERMRPRKRQGSVRRRVC93H169N41O23S2
Protein Kinase Cε Peptide Substrate [ERMRPRKRQGSVRRRV];ERMRPRKRQGSVRRRV120253-69-2C83H155N39O21S
Protein Kinase G Substrate [QKRPRRKDTP], 5-FAM labeled;5-FAM-QKRPRRKDTPC74H106N22O21
Protein Kinase G Substrate [QKRPRRKDTP], 5-TMR labeled;5-TMR-QKRPRRKDTPC82H120ClN25O21
Protein Kinase G Substrate [QKRPRRKDTP], Biotinylated;Biotin-QKRPRRKDTPC63H110N24O17S
Protein Kinase G Substrate [QKRPRRKDTP], Phosphorylated;QKRPRRKD-pT-PC53H97N22O18P
Protein Kinase p34 (cd2) Substrate [ADAQHATPPKKKRKVEDPKDF], 5-FAM labeled;5-FAM-ADAQHATPPKKKRKVEDPKDFC127H182N32O38
Protein Kinase p34 (cd2) Substrate [ADAQHATPPKKKRKVEDPKDF], 5-TMR labeled;5-TMR-ADAQHATPPKKKRKVEDPKDFC135H196ClN35O38
Protein Kinase p34 (cd2) Substrate [ADAQHATPPKKKRKVEDPKDF], Biotinylated;Biotin-ADAQHATPPKKKRKVEDPKDFC116H186N34O34S
Protein Kinase p34 (cd2) Substrate [ADAQHATPPKKKRKVEDPKDF], Phosphorylated;ADAQHA-pT-PPKKKRKVEDPKDFC106H173N32O35P
Protein Tyrosine Phosphatase 1B Substrate [ELEF-pY-MDYE-NH2], 5-FAM labeled;5-FAM-ELEF-pY-MDYE-NH2C78H87N10O28PS
Protein Tyrosine Phosphatase 1B Substrate [ELEF-pY-MDYE-NH2], 5-TMR labeled;5-TMR-ELEF-pY-MDYE-NH2C86H101ClN13O28PS
Protein Tyrosine Phosphatase 1B Substrate [ELEF-pY-MDYE-NH2], Acetylated;Ac-ELEF-pY-MDYE-NH2C59H79N10O23PS
Protein Tyrosine Phosphatase 1B Substrate [ELEF-pY-MDYE-NH2], Biotinylated;Biotin-ELEF-pY-MDYE-NH2C67H91N12O24PS2
Protein Tyrosine Phosphatase 1B Substrate [ELEF-pY-MDYE-NH2];ELEF-pY-MDYE-NH2C57H77N10O22PS
Protein Tyrosine Phosphatase Substrate I [END-pY-INASL], 5-FAM labeled;5-FAM-END-pY-INASLC65H78N11O27P
Protein Tyrosine Phosphatase Substrate I [END-pY-INASL], 5-TMR labeled;5-TMR-END-pY-INASLC73H92ClN14O27P
Protein Tyrosine Phosphatase Substrate I [END-pY-INASL], Biotinylated;Biotin-END-pY-INASLC54H82N13O23PS
Protein Tyrosine Phosphatase Substrate I [ENDYINASL], Biotinylated, Non phosphorylated;Biotin-ENDYINASLC54H81N13O20S
Pro-TGF-α;HADLLAVVAASQC52H88N16O16
Pro-TNF-α (71-82), human;SPLAQAVRSSSRC51H91N19O18
Proto-Oncogene Tyrosine Protein Kinase Src Fragment IG-11, FITC-labeled;FITC-LC-IEDNEYTARQGC80H102N18O28S
Prototype of RGD-containing peptide, FITC-labeled;FITC-LC-GRGDSP
PrP (106-114);KTNMKHMAGC41H72N14O12S2
PrP (113-126);AGAAAAGAVVGGLGC44H76N14O15
PrP (127-147);GYMLGSAMSRPIIHFGSDYEDC103H152N26O33S2
PrP (57-64);WGQPHGGGC35H46N12O10
PrP (89-106);WGEGGGTHSEWNKPSSKPKC91H135N27O28
PSA1(141-150) ??;FLTPKKLQCV160215-60-1C55H93N13O13S
PSA2 (146–154) ??;KLQCVDLHV
PTD-p50 (NLS) Inhibitory Peptide;DRQIKIWFQNRRMKWKKVQRKRQKLMPC164H275N55O35S2
PTD-p65-P1 Peptide;DRQIKIWFQNRRMKWKKQLRRPSDRELSEC169H277N57O44S
PTD-p65-P6 (Ser529/536) Inhibitory Peptide;DRQIKIWFQNRRMKWKKNGLLSGDEDFSSC160H250N48O45S
PTD-TRAF6 Inhibitory Peptide;DRQIKIFQNRRMKWKKRKIPTEDEYC147H240N46O39S
QA-GSH?
Rab24 (179-199);QVMTEDKGVDLSQKANPYFYSC107H162N26O36S
RAGE derived peptide??;SPSSNRIRNT
Rat Renin Inhibitor Peptide, WFML Peptide;Ac-HPFV-(Sta)-LF-NH2C51H74N10O9
Renin FRET Substrate I;(DABCYL-g-Abu-Ile-His-Pro-Phe-His-Leu-Val-Ile-His-Thr-EDANS)142988-22-5C90H120N22O16S
Renin Inhibitor III??;RRPFH-Sta-IHK-NH2
RET S1 Hydrolysis Product 1;Ac-DED(EDANS)-EEAbuC41H54N8O20S
RET S1 Hydrolysis Product 2;Lac-SK(DABCYL)-NH2C27H37N7O6
RPI (Prenyl Protein Inhibitor)C40H70N4O7S2
RRA-pS-PVA;RRA-pS-PVAC31H58N13O12P
RRLIEDAEYAARG, Amide, 5-FAM labeled;5-FAM-RRLIEDAEYAARG-NH2C85H117N23O26
RRLIEDAEYAARG, Amide, 5-TMR labeled;5-TMR-RRLIEDAEYAARG-NH2C93H131N26O26+
RRLIEDAEYAARG, Amide, Biotinylated;Biotin-RRLIEDAEYAARG-NH2C74H121N25O22S
RRREEE-pS-EEEAA;RRREEE-pS-EEEAAC62H102N22O27
RRREEE-pT-EEEAA;RRREEE-pT-EEEAAC63H104N22O27
RS-domain derived peptide, FAM-labeled??;5-FAM-GRSRSRSRSR-OH
S6 Kinase Substrate (229-239), Amide, Biotinalyted;Biotin-AKRRRLSSLRA-NH2C64H119N27O15S
S6 Kinase Substrate (229-239), C-term STSKSESSQK;AKRRRLSSLRASTSKSESSQKC95H175N37O33
SAM PEP 1;HMRSAMSGLHLVKRR-NH2C74H132N30O17S2
SARS-CoV PLP2 Optimal Substrate (813-823) FRET??;Abz-FRLKGGAPIKGV-EDDnp
SARS-CoV PLP2 Optimal Substrate (813-823)??;FRLKGGAPIKGV
Scramble-beta-Amyloid (1-40);AEGDSHVLKEGAYMEIFDVQGHVFGGKIFRVVDLGSHNVA
Scramble-beta-Amyloid (1-42);AIAEGDSHVLKEGAYMEIFDVQGHVFGGKIFRVVDLGSHNVA
Phytochelatin-4, biotinylated??;Biotin-LC-(γE-C)4-OH
Pim-1 substrate peptide;AKRRRLSAC39H76N18O10
PKA Inhibitor Substrate;GRTGRRN-pS-IHDILC61H108N25O22P
87 88 89 90 91 92 93 94 95 96 97 98 99 100
Copyright 2019 © ChemicalBook. All rights reserved